Acutus Medical, Inc.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: US0051111096

USD

0.00

0.00 (0.00%)

Dec 04

NAS

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

NeuroOne Medical Technologies Corp.

Singular Genomics Systems, Inc.

Nortech Systems, Inc.

PetVivo Holdings, Inc.

Sientra, Inc.

Acutus Medical, Inc.

LENSAR, Inc.

Modular Medical, Inc.

PAVmed, Inc.

Check-Cap Ltd.

LumiraDX Ltd.

Why is Acutus Medical, Inc. ?

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Operating profit has grown by an annual rate 17.68% of over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -12.24

Flat results in Sep 24

Risky - Negative Book Value

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -99.86%, its profits have risen by 100%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -99.86% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Acutus Medical, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Acutus Medical, Inc.

-99.5%

-0.02

5422.05%

S&P 500

13.22%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

31.79%

EBIT Growth (5y)

17.68%

EBIT to Interest (avg)

-12.24

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.68

Sales to Capital Employed (avg)

0.41

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

19.30%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

-0.01

EV to EBIT

-3.20

EV to EBITDA

-3.84

EV to Capital Employed

2.47

EV to Sales

0.97

PEG Ratio

Dividend Yield

ROCE (Latest)

-77.32%

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

Bearish

Bollinger Bands

Sideways

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for Acutus Medical, Inc.

Raw Material Cost

Fallen by -111.24% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales